Answers are grounded in this paper and cite their sources.
Using the example of cathepsin K, we demonstrate the design of highly potent and selective azadipeptide nitrile inhibitors. A systematic scan with respect to P2 and P3 substituents was carried out. Structural modifications strongly affected the enzyme-inhibitor association (but not dissociation) rate. A combination of optimized P2 and P3 substituents with a methylation of the P3-P2 amide linker resulted in the picomolar cathepsin K inhibitor 19 with remarkable selectivity over cathepsins L, B, and S.
No takes yet. Share an insight, caveat, or question.
Frizler et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: